Your browser doesn't support javascript.
loading
Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021.
Tunheim, Gro; Rø, Gunnar Øyvind Isaksson; Chopra, Adity; Aase, Audun; Kran, Anne-Marte Bakken; Vaage, John Torgils; Lund-Johansen, Fridtjof; Hungnes, Olav.
Afiliação
  • Tunheim G; Division of Infection Control, Norwegian Institute of Public Health (NIPH), Oslo, Norway.
  • Rø GØI; Division of Infection Control, Norwegian Institute of Public Health (NIPH), Oslo, Norway.
  • Chopra A; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Aase A; Division of Infection Control, Norwegian Institute of Public Health (NIPH), Oslo, Norway.
  • Kran AB; Division of Infection Control, Norwegian Institute of Public Health (NIPH), Oslo, Norway.
  • Vaage JT; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Lund-Johansen F; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Hungnes O; Department of Immunology, Oslo University Hospital, Oslo, Norway.
Influenza Other Respir Viruses ; 16(6): 1004-1013, 2022 11.
Article em En | MEDLINE | ID: mdl-35770841

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article